Kyndryl and MedStar Health have inked a five-year deal, under which Kyndryl will provide mission critical IT capabilities across the MedStar Health system.
Merck has inked a ten-year strategic partnership agreement with cloud solutions company Veeva.
Cleveland Clinic and IBM have begun deployment of the first private sector onsite, IBM-managed quantum computer in the United States, says IBM.
Amazon has entered into a definitive merger agreement with One Medical, a national primary care healthcare provider.
Neuro42, a medical imaging, robotics, and AI technology company, has inked an exclusive licensing agreement with Johns Hopkins University for their MR compatible robot.
Google Cloud will invest $100 million into telehealth provider Amwell, as part of a multi-year partnership to deliver telehealth solutions.
Sectra will install its enterprise imaging solution at Michigan Medicine, University of Michigan, as per a contract signed in July, the company said in a statement.
A medical center at Mass General, is adopting Nvidia DGX A100 AI systems, the company said in a statement.
The Wake Forest Institute for Regenerative Medicine (WFIRM) and Oracle Health Sciences have teamed to study new approaches to establishing the safety of new drugs.
Johns Hopkins Medicine (JHM) has inked a five-year relationship with Microsoft, centered on Microsoft’s Azure and analytical tools.
Health information technology company McKesson has inked a technology collaboration with Google Cloud.
Walgreens Boots Alliance and Microsoft have joined forces to develop new health care delivery models and technology.
OSI Systems has received an order valued at approximately $6 million to provide patient monitoring solutions and related accessories to a U.S. based hospital.
Munich-based Brainlab, a company that develops, manufactures and markets software-driven medical technology, has inked an exclusive agreement with Magic Leap.
Atomwise has entered into an evaluation agreement with Pfizer, in which the drug giant will evaluate Atomwise’s platform to identify potential drug candidates.